Ross Clark is a leader writer and columnist who has written for The Spectator for three decades. He writes on Substack, at Ross on Why?
From our UK edition
Should we believe the conclusions of the World Health Organization (WHO) report into the origins of the SARS-CoV-2 virus which, as expected, dismissed the possibility of a laboratory accident while giving credence to the theory that the virus was imported via frozen foods? The first thing to note is that the report does not even claim to
From our UK edition
Get ahead with vaccination and you can open up your country sooner. It seems logical, but it is not quite how things are working in Britain, where in spite of this week’s relaxation our lockdown restrictions remain among the toughest in the world. This applies even less in Chile. On 29 March, 6.53 million of
From our UK edition
To most of us, cryptocurrencies remain an esoteric world, beloved by nerds and incomprehensible to the rest of us. Does Visa’s announcement this week that it will now process payments directly in a cryptocurrency called USDCoin change that, and hasten us to a day when we will all have cryptocurrency accounts which we use to
From our UK edition
The story of Covid has been one of government repeatedly ruling things out – and then coming back several weeks later and introducing them nonetheless. It happened with lockdown, compulsory wearing of masks, and now it looks as if it might be happening with vaccine passports. Remember vaccines minister Nadhim Zahawi telling us of vaccine
From our UK edition
The AstraZeneca vaccine has been under attack ever since the results of its phase three trials were announced in December. When the results of US trials were released this week showing 79 per cent efficacy against symptomatic disease and 100 per cent protection from serious cases of Covid 19 – and failing to show up any
From our UK edition
‘Unloved’ is an adjective often applied to British shares in recent years. A more appropriate description might be ‘abandoned, with half a dozen kids and the rent unpaid’. Since referendum day in June 2016 the FTSE100 index has grown by 10 per cent. Over the same period the Hang Seng is up 42 per cent, the DAX
From our UK edition
Covid deaths fell to 17 on Sunday, the lowest daily figure since 28 September and no higher than the levels being recorded throughout much of last summer. Deaths are down over 40 per cent on the week, hospitalisations down 21 per cent. Yet the better the news on vaccinations and serious illness, the longer the
From our UK edition
The hesitancy of many European countries to use the AstraZeneca vaccine (between bouts of complaining the company hasn’t delivered enough doses) has been widely reported. Less discussed is the delay in US authorities approving the vaccine for use there. But with the reporting of results from a US trial, that should now be a formality.
From our UK edition
There is a big, big hole in Ursula von der Leyen’s strategy of threatening to ban exports of the Pfizer vaccine to Britain unless Britain hands over shots of UK-made AstraZeneca vaccine to make up for a shortfall in EU-made supplies. Well, several holes perhaps – not least that EU member states have done their
From our UK edition
The UK vaccination programme has been such a success to date that until yesterday evening it seemed a formality that the government would achieve its target of offering all adults at least a first dose of a Covid vaccine by July. Indeed, on Monday it looked as if this date might be brought forwards when
From our UK edition
Should the Bank of England be jacking up interest rates whenever the housing market starts to run away with itself? That is what the Reserve Bank of New Zealand has in effect just been asked to do by Jacinda Ardern’s government: to take into account a ‘sustainable housing market’ when fixing its monetary policy. If
From our UK edition
Far from subsiding, as it seemed to be doing last week, the European war over the AstraZeneca vaccine has intensified. Over the past few weeks, EU leaders have swung from accusing the company – and Britain – of hoarding the vaccine and failing to supply it to EU countries, to claiming that it is ineffective,
From our UK edition
As the chief medical officer professor Chris Whitty suggested this week, the situation with Covid figures can change very sharply, very quickly. One moment infection numbers can be falling, like they were in late November, but the next moment, they can take off again — as they subsequently did in mid-December. That is why all eyes are now on the
From our UK edition
Punters have been warning about the over-valuation of tech stocks for so long that great fortunes have been made in the interim. Then again, anyone old enough to remember back 20 years will know that tech stocks are not invincible – they can indeed crash. So is the wobble in tech stocks since the middle
From our UK edition
At the beginning of the year, Boris Johnson and his advisers were at pains to tell us that by spring we would be in a vastly better situation with Covid. Well, spring is here, the number of new infections and deaths is falling by around 30 per cent week on week, deaths are back to
From our UK edition
Will the return of schools reverse, or dramatically slow, the sharp downwards trend in new Covid-19 infections, which is currently falling at more than 30 per cent a week? No one knows for sure, but it seems unlikely that the mass return of schools today will not have some effect on infections in England, especially
From our UK edition
According to government figures the toll of Covid 19 so far has been 124,419 deaths (if you define a Covid death as any death which occurs within 28 days of someone being confirmed as infected with the virus) or 140,062 (if you define a Covid death as one where the word ‘Covid’ is mentioned anywhere
From our UK edition
How strong is the link between obesity and the danger of dying from Covid? Yesterday, the World Obesity Federation published a report containing a widely-quoted statistic that 2.2 million out of 2.5 million Covid deaths globally have occurred in countries where more than half the population is overweight. The figure is stark, although also highly
From our UK edition
Imperial College’s REACT study is given a prominence over other Covid data, but it is a struggle to understand why. This morning, as so often, BBC news bulletins included the latest tranche of results from the study, suggesting that the fall in new Covid infections is ‘slowing’. The data appears to confirm a deceleration in
From our UK edition
Buy when there is gunfire on the streets, goes the old adage. But could this be a case of the right time to buy being when there is, well, hardly anything happening on the streets? Few investments have been as hard hit by Covid-19 as commercial property in central London. As shops and restaurants have